![Tristan Peitz](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Tristan Peitz
Geen lopende functies
Loopbaan van Tristan Peitz
Eerdere bekende functies van Tristan Peitz
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
QSAM BIOSCIENCES, INC. | Directeur/Bestuurslid | 01-05-2017 | 09-12-2020 |
Independent Dir/Board Member | 01-05-2017 | 09-12-2020 | |
Cohen Capital Management, Inc. (California)
![]() Cohen Capital Management, Inc. (California) Investment ManagersFinance Cohen Capital Management, Inc. (CCM) is a registered independent wealth management firm headquartered in Corte Madera, California. The firm was founded by Jay A. Cohen in 1995. CCM manages clients’ cash balances, equity and fixed income portfolios on a fully disclosed basis primarily for high net-worth individuals. | Portfolio Manager-Fixed Income | 01-05-2010 | 01-07-2019 |
Trading-Fixed Income | 01-05-2010 | 01-07-2019 |
Opleiding van Tristan Peitz
Stephen M. Ross School of Business | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 4 |
Operationeel
Portfolio Manager-Fixed Income | 1 |
Trading-Fixed Income | 1 |
Director/Board Member | 1 |
Sectoraal
Finance | 2 |
Process Industries | 2 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Cohen Capital Management, Inc. (California)
![]() Cohen Capital Management, Inc. (California) Investment ManagersFinance Cohen Capital Management, Inc. (CCM) is a registered independent wealth management firm headquartered in Corte Madera, California. The firm was founded by Jay A. Cohen in 1995. CCM manages clients’ cash balances, equity and fixed income portfolios on a fully disclosed basis primarily for high net-worth individuals. | Finance |
QSAM Biosciences, Inc.
![]() QSAM Biosciences, Inc. Chemicals: AgriculturalProcess Industries QSAM Biosciences, Inc. engages in the provision of nuclear medicines for the treatment of cancer and related diseases and conditions. It also focuses on the development of its licensed radiopharmaceutical drug candidate, Samarium-153-DOTMP or CycloSam. The company was founded by Christopher M. Nelson, Douglas R. Baum and C. Richard Piazza on August 26, 2004 and is headquartered in Austin, TX. | Process Industries |
- Beurs
- Insiders
- Tristan Peitz
- Ervaring